Dermatologic Manifestations of Hepatitis C Infection and the Effect of Interferon Therapy: A Literature Review

被引：1
|
作者：
Jadali, Zohreh [1 ]
机构：
[1] Univ Tehran Med Sci, Dept Immunol, Sch Publ Hlth, Tehran 14155, Iran
来源：
ARCHIVES OF IRANIAN MEDICINE | 2012年 / 15卷 / 01期
关键词：
hepatitis C virus; interferon; skin manifestations; PORPHYRIA-CUTANEA-TARDA; OF-THE-LITERATURE; CHRONIC MYELOGENOUS LEUKEMIA; ALPHA-INDUCED SARCOIDOSIS; ORAL LICHEN-PLANUS; VIRUS-INFECTION; MIXED CRYOGLOBULINEMIA; PLUS RIBAVIRIN; EXTRAHEPATIC MANIFESTATIONS; T-CELLS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The skin could be a main target organ for extrahepatic manifestations in hepatitis C virus- (HCV) infected patients and research data suggest that interferon treatment may be associated with immune-mediated skin lesions. However, case reports propose that the response of dermatologic extrahepatic manifestations to interferon in patients with chronic HCV is greatly different. The objective of this study is to summarize currently available data on dermatologic conditions associated with chronic HCV infection. In addition, we investigate the incidence of the development of immune mediated dermatologic disorders during interferon therapy in these patients.
引用
收藏
页码：43 / 48
页数：6
相关论文
共 50 条
  • [31] Interferon therapy for hepatitis C
    Preston, H
    Wright, TL
    LANCET, 1996, 348 (9033): : 973 - 974
  • [32] Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: Case report and review of the literature
    Midturi, J
    Hoffman, MS
    Hurley, D
    Winn, R
    Beissner, R
    Carpenter, J
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (11) : 1724 - 1729
  • [33] Timing of interferon therapy and sources of infection in patients with acute hepatitis C
    Ogata, K
    Ide, T
    Kumashiro, R
    Kumada, H
    Yotsuyanagi, H
    Okita, K
    Akahane, Y
    Kaneko, S
    Tsubouchi, H
    Tanaka, E
    Moriwaki, H
    Nishiguchi, S
    Kakumu, S
    Mizokami, M
    Iino, S
    Sata, M
    HEPATOLOGY RESEARCH, 2006, 34 (01) : 35 - 40
  • [34] Hepatitis C virus infection and interferon therapy in patients with Down syndrome
    Miyoshi, Yoko
    Tajiri, Hitoshi
    Okaniwa, Mariko
    Terasawa, Sousuke
    Fujisawa, Tomoo
    Iizuka, Toshiyuki
    Ozono, Keiichi
    PEDIATRICS INTERNATIONAL, 2008, 50 (01) : 7 - 11
  • [35] Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection
    Battaglia, AM
    Hagmeyer, KO
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (04) : 487 - 494
  • [36] SYMPTOMATIC MYOPATHY IN HEPATITIS-C INFECTION WITHOUT INTERFERON THERAPY
    HORSMANS, Y
    GEUBEL, AP
    LANCET, 1995, 345 (8959): : 1236 - 1236
  • [37] Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection
    Shiratori, Y
    Kato, N
    Yokosuka, O
    Imazeki, F
    Hashimoto, E
    Hayashi, N
    Nakamura, A
    Asada, M
    Kuroda, H
    Tanaka, N
    Arakawa, Y
    Omata, M
    GASTROENTEROLOGY, 1997, 113 (02) : 558 - 566
  • [38] INTERFERON THERAPY IN CHRONIC HEPATITIS-C VIRUS-INFECTION
    WEILAND, O
    FEMS MICROBIOLOGY REVIEWS, 1994, 14 (03) : 279 - 288
  • [39] Interferon-lambda and therapy for chronic hepatitis C virus infection
    Donnelly, Raymond P.
    Dickensheets, Harold
    O'Brien, Thomas R.
    TRENDS IN IMMUNOLOGY, 2011, 32 (09) : 443 - 450
  • [40] Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus
    Foster, GR
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) : 685 - 691
12345